(Q44487898)

3 December 2017

title

Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS). (English)

1 reference

3 December 2017

Stefan Foser

1

1 reference

3 December 2017

Alfred Schacher

2

1 reference

3 December 2017

Karl A Weyer

3

1 reference

3 December 2017

Doris Brugger

4

1 reference

3 December 2017

Elke Dietel

5

1 reference

3 December 2017

Stefan Marti

6

1 reference

3 December 2017

Thomas Schreitmüller

7

1 reference

3 December 2017

language of work or name

1 reference

1 July 2003

1 reference

Protein Expression and Purification

3 December 2017

published in

1 reference

3 December 2017

volume

30

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

78-87

1 reference

How cells respond to interferons

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Clinical Pharmacokinetics of Interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Pegylation: a novel process for modifying pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

Convenient assay for interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900055-X

7 January 2021

10.1016/S1046-5928(03)00055-X

Identifiers

DOI

1 reference

3 December 2017

1 reference